Skip to main content

and
  1. No Access

    Article

    Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas

    The management of adult patients with grade 2 gliomas remains a challenge for the clinical neuro-oncologist. Several clinical prognostic factors appear to be as important as treatment factors in determining ou...

    A. Smits, E. Westerberg, D. Ribom in European Journal of Nuclear Medicine and M… (2008)

  2. Article

    Open Access

    PROX1 is a predictor of survival for gliomas WHO grade II

    The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers ...

    T Elsir, M Qu, S G Berntsson, A Orrego, T Olofsson in British Journal of Cancer (2011)